Health Trials

The Homburg Keratoconus Center (HKC)

ConditionKeratoconus
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorUniversität des Saarlandes

About this trial

Aim of this study is to conduct longitudinal and cross-sectional analyses about the corneal ectatic disease Keratoconus based on data obtained from Keratoconus patients in the Homburg Keratoconus Center (HKC).

The Homburg Keratoconus Center (HKC) was founded in 2010 and, up to now, comprises more than 3,000 Keratoconus patients. Topographic, tomographic and biomechanic characteristics of the disease are being analyzed with the intention to elucidate how the disease begins and develops during lifetime.

Eligibility criteria

Qualifiers

All Keratoconus patients presenting in the department of ophthalmology, Saarland University Medical Center, Homburg, Saarland, Germany.

Disqualifiers

Patients without Keratoconus.

Trial design

Treatments tested in this trial

  • Topographic, tomographic and biomechanical analysis.

Treatment groups

5,000 Participants
are divided into 1 treatment group

Locations

1
Department of Ophthalmology66421, HomburgSaarland, Germany

Sponsors and collaborators

Universität des Saarlandes

Lead sponsor

University Hospital, Saarland

Sponsor institution

Source ClinicalTrials.gov